WebMar 17, 2024 · The device uses a drug coated balloon to dilate the urethra at the site of the stricture. The balloon is coated on its outer surface with paclitaxel, which is then … WebFeb 28, 2024 · One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume ® Drug-Coated Balloon for Anterior Urethral Strictures. J Urol. 2024 Dec 2:101097JU0000000000002346. doi ...
(PDF) Optilume® drug-coated balloon dilation in complex female urethral …
WebDec 13, 2024 · The Optilume® drug-coated balloon technology provides a low cost, minimally invasive treatment option for men suffering from urinary tract conditions like urethral strictures and benign prostatic ... WebApr 10, 2024 · PDF On Apr 10, 2024, Laura Kelly and others published Economic evaluation of Optilume, a drug‐coated balloon for recurrent anterior male urethral stricture Find, … church christmas banquet table decorations
Optilume drug-coated balloon superior to standard care for …
WebApr 10, 2024 · In conclusion, the findings of this analysis support the use of Optilume urethral drug-coated balloon as an alternative to the standard of care endoscopic management in the treatment of men with recurrent anterior male urethral stricture in England. This was shown in the base case scenario and in the results of the deterministic … WebMar 1, 2024 · We describe the first Optilume® urethral drug-coated balloon dilation for female urethral stricture disease involving the sphincter. After six months follow-up the patient remains stricture free with full continence and complete bladder emptying. Keywords Drug-coated balloon dilation Urethral stricture Optilume Female urethral stricture 1. WebDec 15, 2024 · Urotronic’s Optilume urethral drug coated balloon has been approved for use in the US market and will challenge the current standard-of-care endoscopic treatments for male urethral strictures. On December 13 2024, the US FDA approved the Optilume balloon for use in male urethral strictures. detweiler family medicine portal